Drug Type Small molecule drug |
Synonyms Alto, Ascophyllum, Sodium alginate (JAN/NF) + [4] |
Target- |
Action- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date Japan (26 Jun 2009), |
Regulation- |
Molecular FormulaC15H18ClN3O |
InChIKeyUFNOUKDBUJZYDE-UHFFFAOYSA-N |
CAS Registry94361-06-5 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D03336 | - | - | - |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Duodenal Ulcer | Japan | 26 Jun 2009 | |
Erosive gastritis | Japan | 26 Jun 2009 | |
Esophagitis, Peptic | Japan | 26 Jun 2009 | |
Hemorrhage | Japan | 26 Jun 2009 | |
Stomach Ulcer | Japan | 26 Jun 2009 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Dyspepsia | Phase 3 | China | 05 Jun 2013 | |
Erosive gastro-esophageal reflux disease | Phase 3 | China | 05 Jun 2013 | |
Gastroesophageal Reflux | Phase 3 | China | 05 Jun 2013 | |
Gastroesophageal Reflux | Phase 3 | China | 05 Jun 2013 |
Not Applicable | - | xaodkwsrww(vhmfkakmvt) = xjtpcxanyy lcxqmmvpaj (riahnnikkx ) | - | 15 Oct 2023 | |||
Different PPI | xaodkwsrww(vhmfkakmvt) = xqxyohddif lcxqmmvpaj (riahnnikkx ) | ||||||
Not Applicable | - | Oral alginate (Gaviscon Advance) | vnrnhegdpu(gikaxbaoen) = kbwzawqetv nxojateqrd (dyviegagca, 47–190) | - | 01 Oct 2017 | ||
Placebo | vnrnhegdpu(gikaxbaoen) = vkjzasacwd nxojateqrd (dyviegagca, 34–107) |